PDB39 EFFECT OF VARYING MODELLING ASSUMPTIONS ON THE COSTEFFECTIVENESS OF LIRAGLUTIDE 1.2 MG (AS A COMPONENT OF DUAL THERAPY) IN TYPE 2 DIABETES
Abstract
Authors
WJ Valentine BD Chubb IC Smith
WJ Valentine BD Chubb IC Smith
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now